Circulating Tumour Cells in Patients With Peritoneal Metastases

Cirkulerande Tumörceller Hos Patienter Med Bukhinnespridda tumörer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04083547

Enrollment

114

Registered

2019-09-10

Start date

2017-10-17

Completion date

2020-11-01

Last updated

2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulating Tumor Cell, Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastases

Brief summary

This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.

Detailed description

CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.

Interventions

DIAGNOSTIC_TESTiCellate

New method of circulating tumour cell detection and capture.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Peritoneal metastases being treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Prognostic value	2 year.	Prediction of survival and recurrence according to the occurrence of CTCs.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026